Evidence map›Paper›PMID 19749155›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2009

Decreased PPAR gamma expression compromises perigonadal-specific fat deposition and insulin sensitivity.

Yau-Sheng Tsai, Pei-Jane Tsai, Man-Jin Jiang, Ting-Yu Chou, Avani Pendse, Hyung-Suk Kim, Nobuyo Maeda

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Genetic variations in peroxisome proliferator-activated receptor gamma expression affect blood pressure.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yau-Sheng TsaiInstitute of Clinical Medicine, National Cheng Kung University, Tainan 701, Taiwan, Republic of China. yaustsai@mail.ncku.edu.tw
Pei-Jane Tsai
Man-Jin Jiang
Ting-Yu Chou
Avani Pendse
Hyung-Suk Kim
Nobuyo Maeda
University of North Carolina at Chapel Hill · USNational Cheng Kung University · TW

Funding

APOLIPOROTEIN GENES AND ATHEROGENESISR01HL042630 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAEDA, NOBUYO · 1989 to 2017
$4.9M
APOLIPOPROTEIN GENES AND ATHEROGENESIS IN ANIMALSR37HL042630 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAEDA, NOBUYO · 1998 to 2007
$3.4M
Testing Human Quantitative Genomic Variations in MiceR01HL077145 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAEDA, NOBUYO · 2005 to 2009
$1.8M
Phenogenomics of human PPARgamma mutationsR01DK067320 · NIDDK · INSTITUT/GENETIQUE/BIOLOGIE MOLEC/CELL · PI AUWERX, JOHAN · 2005 to 2008
$1.5M
NHLBI NIH HHS HL077145NHLBI NIH HHS HL42630NHLBI NIH HHS R01 HL042630NHLBI NIH HHS R01 HL077145NHLBI NIH HHS R37 HL042630NIDDK NIH HHS DK067320NIDDK NIH HHS R01 DK067320
6 · The paper itself

Abstract

Mutations and polymorphisms in PPARG have been linked to adiposity and partial lipodystrophy in humans. However, how disturbances in PPARG lead to depot-specific effects on adipose tissue, as shown by the characteristic aberrant fat distribution in patients, remains unclear. By manipulating the 3'-untranslated region of the Pparg gene, we have generated mice with peroxisome proliferator-activated receptor gamma (PPAR gamma) gene expression ranging from 25% to 100% normal. Basal levels of PPAR gamma transcripts between 50% and approximately 100% had no significant effect on body weight, fat mass, and insulin sensitivity. In contrast, mice with 25% normal PPAR gamma expression exhibited reduced body weight and total fat mass, insulin resistance, and dyslipidemia. Interestingly, fat mass was selectively reduced in perigonadal depot without significant changes in inguinal and other depots. Expression of adipogenic factor CCAAT enhancer binding protein-alpha and some other metabolic genes containing peroxisome proliferator response element were reduced in a perigonadal depot-specific fashion. This was further associated with depot-specific reduction in the expression of adipokines, increased expression of TNFalpha, and increased ectopic lipid deposition in muscles. Together, these results underscore the differential sensitivity of the individual fat depots on PPAR gamma availability as an underlying mechanism of partial lipodystrophy.

Indexed as

Gene Expression RegulationAdipocytesAllelesAnimalsBody CompositionEnhancer Elements, GeneticFemaleGlucose Tolerance TestGonadsInsulin ResistanceLipid MetabolismLipodystrophyMaleMiceMice, TransgenicPPAR gammaPPAR gammaTumor Necrosis Factor-alpha

Identifiers

PMID19749155
PMCPMC2775941
OpenAlexW1988794445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.